Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies
- Supplementary File 1:
ZIP-Document (ZIP, 95 KiB)
Zhou, H.; Dcosta, B.M.; Landau, N.R.; Tada, T. Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies. Viruses 2022, 14, 1334. https://doi.org/10.3390/v14061334
Zhou H, Dcosta BM, Landau NR, Tada T. Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies. Viruses. 2022; 14(6):1334. https://doi.org/10.3390/v14061334
Chicago/Turabian StyleZhou, Hao, Belinda M. Dcosta, Nathaniel R. Landau, and Takuya Tada. 2022. "Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies" Viruses 14, no. 6: 1334. https://doi.org/10.3390/v14061334